CHO

Singapore: An Emerging Leader in Biomedical Sciences

October

2007

SBE Special Section

Miranda G. S. Yap, Niki S. C. Wong

With a heavy investment in biomedical research— particularly the $330 million to build Biopolis in 2003— Singapore is seeing the fruits of its labor blossom.

Towards Genome Engineering in Chinese Hamster Ovary Cells

SBE Webinar

Dec 14, 2010

Wei shou Hu

Worth over $30 billion, therapeutic proteins, produced by recombinant mammalian cells, have been the fastest growing class of medicines in industrialized nations.

Recombinant Protein Therapeutics from CHO Cells -- 20 Years and Counting

October

2007

SBE Special Section

Karthik P. Jayapal, Katie F Wlaschin, Wei-Shou Hu and Miranda G. S. Yap , Wei shou Hu

The CHO cell is at its height of technological prominence thanks to its adaptability to various culture conditions and plasticity in the context of genetic alterations. With further research, the application ofCell Culture Strategies based on...

Deciphering the Mechanisms of Therapeutic Protein Production

October

2007

SBE Special Section

Christoph L. Bausch, Daniel W. Allison, Kevin J. Kayser, Matthew V. Caple, Trissa Borgschulte

Demand for therapeutic recombinant proteins will eventually exceed current production capabilities. This is a major driver in further understanding Chinese Hamster Ovary (CHO) cell biology, which is the cell line of choice for producing these...

Industry and SBE News

October

2007

SBE Special Section

Dr. George Georgiou to Receive SBE's James E. Bailey Award; Averting an Epidemic— Novel Device Detects Avian Flu Virus in Less than Half an Hour; Cell-Free Protein Sythesis Comes of Age; Genetically Engineering Microorganisms into Pharmaceutical...

Search form